From November 17 to 18, 2025, the Business & Philanthropy Forum was held in Singapore. Centered on the theme “Global Vision: Wealth and Capital for Good,” the forum focused on modules such as global landscape and strategic positioning, technological innovation and digital transformation, and medical technology and the future of health. Through keynote speeches, closed-door dialogues, interactive sessions, and practical case studies, the event showcased cutting-edge knowledge and insights, serving as an important platform to promote medical innovation and support enterprises in expanding overseas.

At the Medical Technology Innovation Company Awards Ceremony held on November 18, the “Top 40 Chinese Innovative Drug Companies Leading Global Expansion 2025” list was released. United Laboratories was ranked 10th on the list in recognition of its outstanding performance in innovative drug R&D, global presence, and international collaboration. This not only affirms United Laboratories’ innovation capabilities and global strategy but also serves as an encouragement for China’s innovative drug industry in its efforts to expand internationally.

TUL will continue to accelerate scientific innovation and international collaboration, helping Chinese innovative drugs deliver “for good” medical value on the global stage.